Olympus Set to Demonstrate Newest Endoscopy System at DDW

Friday, May 05, 2023

Olympus Corporation, a renowned global medical technology company focused on improving people's health and well-being, has announced that it will showcase its most advanced endoscopy system, the EVIS X1, for the first time in the United States. This demonstration will take place at the Digestive Disease Week (DDW) annual meeting in Chicago from May 6-9.

The EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes (the GIF-1100 for the upper digestive tract and the CF-HQ1100DL/I for the lower digestive tract), recently received FDA 510(k) clearance and will be on display during the event. These endoscopes feature the lightweight ErgoGrip control section, designed with a rounded handle and easily accessible angulation control knobs and switches to accommodate users with small hands and enhance scope maneuverability.

Key features of the EVIS X1 endoscopy system include:

  1. Texture and Color Enhancement Imaging (TXI): TXI technology enhances the visibility of lesions and polyps by improving image color and texture.
  2. Red Dichromatic Imaging (RDI): RDI technology enhances the visibility of deep blood vessels and bleeding points.
  3. Brightness Adjustment Imaging with Maintenance of Contrast (BAI-MAC): BAI-MAC technology corrects brightness levels in dark areas of the endoscopic image while maintaining brightness in lighter areas, thereby improving overall visual clarity.
  4. Narrow Band Imaging (NBI): The EVIS X1 endoscopy system continues to feature NBI technology, which enhances visual observation of mucosal and vascular patterns using specific blue and green wavelengths absorbed by hemoglobin.

Richard Reynolds, President of the Medical Systems Group for Olympus America, Inc., expressed excitement about sharing the advancements of their latest endoscopy system with gastroenterologists at the DDW meeting. He emphasized Olympus' commitment to providing cutting-edge endoscopy systems that enable physicians to deliver optimal patient care.

It is important to note that the TXI, RDI, BAI-MAC, and NBI technologies are intended as adjunctive tools for endoscopic examination and are not intended to replace histopathological sampling for diagnosis. These technologies supplement Olympus' white light imaging capabilities.

Olympus encourages interested individuals to visit their booth #3820 during DDW to experience hands-on demonstrations of the EVIS X1 endoscopy system. In addition, Olympus will offer demonstrations of other products, including the TJF-Q190V duodenoscope, VisiGlide guidewires, CleverCut 3V Sphincterotomes, and EndoClot Polysaccharide Hemostatic Spray (PHS). The EndoClot PHS is a powder hemostat used in combination with conventional techniques like clips to control bleeds. Visitors to the booth will have the opportunity to witness how EndoClot PHS works, watch clinical videos, and engage with physicians to understand its application in various procedures. Olympus has exclusive distribution agreements with EndoClot Plus, Inc. for the distribution of EndoClot PHS and Submucosal Injection Solution (SIS) in the U.S. and EMEA markets. These products are utilized in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, or early-stage cancers.

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare CNO Summit - USAHealthcare CMO Summit - USAHealthcare CFO, Financial Strategy & Revenue Cycle SummitHealthcare CEO & Executive Strategy Summit